BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Regenesis Biomedical to Expand Payor Sources to Increase Patient Access


1/9/2012 10:48:36 AM

SCOTTSDALE, Ariz., Jan. 9, 2012 /PRNewswire/ -- Regenesis Biomedical, Inc., a medical technology company that markets the Provant® Therapy System, announced today William (Bill) Gittinger joined the company as Vice President of Reimbursement and Health Economics. In this new role, Bill is chartered with securing expanded payor sources for the Provant Therapy System. Primary emphasis is on Medicare, Medicaid and commercial payors. He is also responsible for demonstrating the cost-effectiveness of the therapy, to increase payor and clinician adoption.

(Logo: http://photos.prnewswire.com/prnh/20120109/LA31405LOGO)

Bill gained relevant experience in leadership positions with Genzyme, Smith & Nephew, Baxter Healthcare and Bionicare. He has a proven track record of developing contracts with payors, public and private, as well as a thorough understanding of clinical and economic data, coding, coverage and payment processes.

"We are pleased Bill is joining us to develop and execute our global reimbursement strategies," said Virginia Rybski, President and CEO of Regenesis. "His background complements the management team, and he will work closely with them as we build our expanded reimbursement capabilities."

Bill graduated from the University of Cincinnati, McMicken College of Arts & Science with a bachelor's degree in biology. He is a certified member of AAPC, the American Association of Professional Coders, and a member of AdvaMed and will represent Regenesis in their Payment Advisory Work Group.

About Regenesis Biomedical

Regenesis Biomedical, Inc. is a privately held medical technology company focused on developing and marketing noninvasive regenerative medicine products. Regenesis developed, patented, and now markets the Provant Therapy System. Our customers include health care facilities, acute care hospitals, long-term acute care hospitals, skilled nursing facilities, rehabilitation centers, home health care agencies, and wound care clinics.

About the Provant® Therapy System

Provant uses pulsed radio frequency energy (PRFE) to facilitate reduction of the pain and edema associated with post-operative, superficial soft tissues.

Contact: Regenesis Biomedical, Inc.
Scott Robey, Vice President Marketing
www.regenesisbio.com Web site
480-970-4970 Phone

SOURCE Regenesis Biomedical Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES